Sinopharm
1099.HK
#2663
Rank
A$9.15 B
Marketcap
A$2.93
Share price
1.70%
Change (1 day)
-22.52%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2025: A$3.47 Billion

According to Sinopharm's latest financial reports the company's current earnings are A$82.21 Billion. In 2025 the company made an earning of A$3.47 Billion, an increase over its 2024 earnings that were of A$3.25 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2025

Annual earnings

Year Earnings Change
2025A$3.47 B6.59%
2024A$3.25 B-27.86%
2023A$4.51 B-0.73%
2022A$4.55 B-1.72%
2021A$4.63 B11.7%
2020A$4.14 B18.44%
2019A$3.50 B10.85%
2018A$3.15 B3.05%
2017A$3.06 B36.48%
2016A$2.24 B7.11%
2015A$2.09 B12.38%
2014A$1.86 B25.05%
2013A$1.49 B22.54%
2012A$1.21 B35.43%
2011A$0.89 B52.24%
2010A$0.59 B30.99%
2009A$0.45 B60.59%
2008A$0.28 B48.29%
2007A$0.18 B123.29%
2006A$84.77 M